← The Lantern · New Carlisle
health · class i

Jubilant Cadista Pharmaceuticals, Inc. recalls Meclizine Hydrochloride Tablets USP, 12.5 mg

The stated reason: Labeling: Label mix-up: Incorrect label placed on product.

Illustration: a small clinic exam room with an exam table, a stethoscope and a clipboard
Illustration · The Lantern

Jubilant Cadista Pharmaceuticals, Inc. began a drug recall on March 08, 2022 whose reported distribution included Ohio. FDA

What the record shows

recalled Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmace… beginning March 08, 2022, in a drug recall whose distribution included Ohio. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride FDA graded it Class I — a reasonable probability that use will cause serious health consequences or death. Quantity affected: 12,174 bottles. The recall is listed as terminated. FDA

1 source

Context

This is one of 1 records of this type (Class I) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2880 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: March 08, 2022 FDA
  • Recall number: D-0767-2022 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Jubilant Cadista Pharmaceuticals, Inc. FDA
  • Product: Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only… FDA
  • Reason for recall: Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets… FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberD-0767-2022
Recalls in this action1
Recalling firmJubilant Cadista Pharmaceuticals, Inc.
ProductMeclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Reason for recallLabeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
ClassificationClass I — a reasonable probability that use will cause serious health consequences or death
Recall typedrug
Quantity12,174 bottles
StatusTerminated
Voluntary or mandatedVoluntary: Firm initiated
Initiated20220308
Reported20220406
DistributionProduct was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
Firm locationSalisbury, MD, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.